艾乐替尼一线治疗ALK阳性晚期非小细胞肺癌显著优于克唑替尼
Alectinib First-Line Treatment ALK-Positive Advanced Non-Small Cell Lung Cancer Was Significantly Better than Crizotinib
艾乐替尼一线治疗ALK阳性晚期非小细胞肺癌显著优于克唑替尼 |
|
评价者：周彩存 |
Alectinib First-Line Treatment ALK-Positive Advanced Non-Small Cell Lung Cancer Was Significantly Better than Crizotinib |
| |